Chalfont St. Giles, England 9/30/08; Boston, MA 9/30/08—GE Healthcare has acquired MicroCal, a developer and manufacturer of microcalorimeters, for an undisclosed amount from majority owner Riverside Partners and other investors. MicroCal’s 2008 revenues are estimated to be $28 million, up from $21 million in 2007, and have grown at more than 25% annually. According to […]

Company Announcements Illumina partnered with Genpathway to provide whole-genome ChIP sequencing services. Illumina named its first certified genetic analysis service provider (CSPro) in Japan, Mitsubishi Chemical Safety Institute, and its first German CSPro, LIFE & BRAIN. Illumina named Fredrick Clerie vice president, Quality Assurance and Regulatory Affairs. He was previously vice president of Global Quality […]

According to South Africa’s “National Survey of Research and Experimental Development: the country’s gross domestic expenditure on R&D totaled ZAR 16,520.6 million ($1.95 billion), 0.95% of GDP, in 2006-2007 for a nominal annual increase of 16.8%. Engineering sciences, natural sciences, and medical and health sciences comprised 20.9%, 20.3% and 15.1% of R&D, respectively. Applied sciences […]

Company Announcements Caliper Life Sciences is bundling DiscovRx’s cell-based GPCR assays with its LabChip platforms. Amnis named Gene Company as the Chinese distributor of its ImageStream in May. Fluxion Biosciences signed an exclusive distribution agreement with Bucher Biotec AG for Switzerland. Accuri Cytometers licensed a time-limited, customized version of De Novo Software’s FCS Expression software […]

New York, NY 9/22/08; South San Francisco, 9/26/08—Citing market instability, Fluidigm has withdrawn its registration statement for an IPO. Fluidigm, which develops microfluidic systems for drug development (see IBO 4/30/08), had originally planned to begin trading on September 19, but postponed the offering several times. Fluidigm had planned to raise $79.5 million in an offering […]

Point-of-care testing (POCT) is contributing to the growth of the diagnostics product market. In the first six months of this year, the FDA approved 152 POC tests. InteLab estimates that POCT represented 35% of the in vitro diagnostics market in 2005 and that, by 2011, it will account for 41%. In 2005, the market for […]

Company Announcements Cambridge Isotope Laboratories acquired the Spectra Stable Isotopes division of Spectra Gases, a subsidiary of Linde Gas, in July. Cambridge Isotope Laboratories agreed to distribute CellFree Sciences’ WEPRO Expression Kits and reagents for cell-free protein production for NMR and MS applications in North America and Europe. Anaspec licensed its HiLytePlus and HiLyte Fluor […]

India’s Central Drugs Standard Control Organization (CDSCO) is preparing plans to enable foreign drug companies to conduct phase I clinical trials in the country, according to a government official. Currently, only Indian companies can conduct phase 0 and I trials domestically. KPMG estimates that India’s clinical research market was worth $200 million in 2007 and […]